Thorne HealthTech IPO
Thorne HealthTech is a personalized health and wellness company that combines nutritional supplements with health testing and digital health solutions. The company focuses on precision medicine approaches to nutrition and wellness, targeting both consumers and healthcare practitioners with science-based products.
What We Know
Thorne HealthTech went public in May 2021 through a merger with a special purpose acquisition company (SPAC) called Kairos Acquisition Corp, trading on the NASDAQ under ticker THRN. The SPAC transaction valued the company at approximately $691 million and provided capital to expand its personalized health platform. Since going public, Thorne has focused on building its digital health capabilities and expanding its direct-to-consumer and healthcare practitioner channels. The company has emphasized its scientific approach to personalized nutrition and has made investments in technology to support its testing and recommendation platform, though like many SPAC-merged companies, it has faced some volatility in its stock performance.
Frequently Asked Questions
Has Thorne HealthTech had an IPO?
Yes, Thorne HealthTech went public in May 2021 through a SPAC merger. The company has been publicly traded on the NASDAQ under ticker THRN since then.
When is the Thorne HealthTech IPO date?
Thorne HealthTech already went public in May 2021, so there is no upcoming IPO date. The company completed its public listing through a SPAC merger.
How can I buy Thorne HealthTech stock?
You can buy Thorne HealthTech stock through any brokerage that offers NASDAQ-listed stocks using the ticker symbol THRN. The stock is available through most major online brokers and trading platforms.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts